CC
TDACU

Centiva Capital’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Centiva Capital’s Portfolio TDACU Stock Details TDACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$1.01M – 2167
2025
Q1 		$1.01M Hold
100,000
– – 0.03% 491
2024
Q4 		$1M Buy
+100,000
New +$1M 0.02% 522

Other funds holding TDACU

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Centiva Capital's TDACU Position: Q2 2025 in Review

Centiva Capital sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 100,000 shares — an estimated $1.01M sold.

Centiva Capital first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $1.01M in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Centiva Capital reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 100,000 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $1.01M.
  • Centiva Capital first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Centiva Capital's Translational Development Acquisition Corp Units position peaked at $1.01M in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.